SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting β2-agonist use in asthma

Eur Respir J. 2020 Feb 12;55(2):1901858. doi: 10.1183/13993003.01858-2019. Print 2020 Feb.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Adrenergic beta-2 Receptor Agonists / therapeutic use
  • Adrenergic beta-Agonists / therapeutic use
  • Asthma* / drug therapy
  • Humans
  • Prescriptions

Substances

  • Adrenergic beta-2 Receptor Agonists
  • Adrenergic beta-Agonists